neostigmine has been researched along with Canine Diseases in 15 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the clinical utility of neostigmine methylsulfate administration in the diagnosis of suspected acquired myasthenia gravis (MG) in dogs and cats." | 8.02 | The clinical utility of neostigmine administration in the diagnosis of acquired myasthenia gravis. ( Beasley, MJ; Cridge, H; José-López, R; Lipsitz, D; Little, A; Menchetti, M; Michaels, JR; Pancotto, T; Suñol, A, 2021) |
| "To assess the clinical utility of neostigmine methylsulfate administration in the diagnosis of suspected acquired myasthenia gravis (MG) in dogs and cats." | 4.02 | The clinical utility of neostigmine administration in the diagnosis of acquired myasthenia gravis. ( Beasley, MJ; Cridge, H; José-López, R; Lipsitz, D; Little, A; Menchetti, M; Michaels, JR; Pancotto, T; Suñol, A, 2021) |
| "Treatment with neostigmine and atropine initially provided control." | 1.26 | Myasthenia gravis in a Fox Terrier litter. ( Jenkins, WL; McDonald, CB; van Dyk, E, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (66.67) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (13.33) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Cridge, H | 1 |
| Little, A | 1 |
| José-López, R | 1 |
| Pancotto, T | 1 |
| Michaels, JR | 1 |
| Menchetti, M | 1 |
| Suñol, A | 1 |
| Lipsitz, D | 1 |
| Beasley, MJ | 1 |
| Foy, DS | 1 |
| Trepanier, LA | 1 |
| Shelton, GD | 1 |
| De Carellan, AG | 1 |
| Pelligand, L | 1 |
| Van Heerden, J | 2 |
| Van Schouwenburg, SJ | 1 |
| Trojaborg, W | 1 |
| Flagstad, A | 1 |
| Verster, A | 1 |
| Gouws, DJ | 1 |
| Breton, L | 1 |
| Gosselin, Y | 1 |
| Couture, L | 1 |
| Aroch, I | 1 |
| Nyska, A | 1 |
| Gal, R | 1 |
| Bark, H | 1 |
| Webb, AA | 1 |
| Taylor, SM | 1 |
| McPhee, L | 1 |
| Jenkins, WL | 1 |
| van Dyk, E | 1 |
| McDonald, CB | 1 |
| Hall, LW | 1 |
| Kellagher, RE | 1 |
| Watkins, SB | 1 |
| Fraser, DC | 1 |
| Palmer, AC | 2 |
| Senior, JE | 1 |
| Parkes, JD | 1 |
| Yealland, MF | 1 |
| Barker, J | 1 |
| Gray, GW | 1 |
| Lorenz, MD | 1 |
| DeLahunta, A | 1 |
| Alstrom, DH | 1 |
15 other studies available for neostigmine and Canine Diseases
| Article | Year |
|---|---|
The clinical utility of neostigmine administration in the diagnosis of acquired myasthenia gravis.
Topics: Animals; Cat Diseases; Cats; Dog Diseases; Dogs; Myasthenia Gravis; Neostigmine; Retrospective Studi | 2021 |
Cholinergic crisis after neostigmine administration in a dog with acquired focal myasthenia gravis.
Topics: Animals; Cholinesterase Inhibitors; Dog Diseases; Dogs; Male; Myasthenia Gravis; Neostigmine; Recept | 2011 |
A case of apparent re-dosing of atracurium during neostigmine reversal in a dog.
Topics: Animals; Atracurium; Atropine; Dog Diseases; Dogs; Female; Medication Errors; Neostigmine; Neuromusc | 2013 |
The use of corticosteroids in a dog with myasthenia gravis.
Topics: Animals; Dog Diseases; Dogs; Female; Myasthenia Gravis; Neostigmine | 1983 |
A hereditary neuromuscular disorder in dogs.
Topics: Animals; Dog Diseases; Dogs; Edrophonium; Electrophysiology; Evoked Potentials; Female; Guanidine; G | 1982 |
Neostigmine-responsive weakness and glomerulonephritis associated with heartworm Dirofilaria immitis infestation in a dog.
Topics: Animals; Diagnosis, Differential; Dirofilaria immitis; Dirofilariasis; Dog Diseases; Dogs; Female; G | 1980 |
[Myasthenia gravis in a young dog (author's transl)].
Topics: Animals; Atropine Derivatives; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Myasthenia Gra | 1981 |
Functional intestinal hypomotility in association with neuronal damage in a dog.
Topics: Animals; Dog Diseases; Dogs; Duodenum; Gastrointestinal Motility; Ileum; Image Processing, Computer- | 1997 |
Focal myasthenia gravis in a dog.
Topics: Animals; Autoantibodies; Cholinesterase Inhibitors; Diagnosis, Differential; Dog Diseases; Dogs; Eso | 1997 |
Myasthenia gravis in a Fox Terrier litter.
Topics: Animals; Atropine; Dog Diseases; Dogs; Male; Myasthenia Gravis; Neostigmine | 1976 |
Respiratory problems after atropine and neostigmine in dogs.
Topics: Anesthesia; Animals; Atracurium; Atropine; Dog Diseases; Dogs; Isoquinolines; Neostigmine; Neuromusc | 1985 |
Myasthenia gravis in the dog.
Topics: Action Potentials; Animals; Dog Diseases; Dogs; Esophageal Diseases; Fatigue; Female; Male; Muscle S | 1970 |
Myasthenia in the dog.
Topics: Action Potentials; Animals; Dog Diseases; Dogs; Electromyography; Esophageal Achalasia; Female; Male | 1974 |
Acute experiments on neuroeffector function in canine esophageal achalasia.
Topics: Acetylcholine; Animals; Atropine; Blood Pressure; Bradycardia; Deglutition; Dog Diseases; Dogs; Elec | 1974 |
Neostigmine-responsive weakness in the dog, similar to myasthenia gravis.
Topics: Administration, Oral; Animals; Atropine; Dog Diseases; Dogs; Hematocrit; Injections, Intramuscular; | 1972 |